Market insights and Product Pipeline

Nootropics Space

APR is 14.4%, equivalent to $5 billion

Specific Product Costs

Varying from $70-85 per kit for certain applications up to $250 per kit for others.

PD & Cognitive Decline Market

Parkinson’s Disease:
$3.4 billion period as of 2022
Cognitive decline:
$ 2.2 billion as of 2021

Anticipated Expansion

Projections suggest potential annual sales for us ranging from $ 500k to 1.5 million within the first 6 months upon product commercialization in 2024

UNLOCK OPPORTUNITIES: MAKE A CHANGE WITH CNS CURATIVE TECHNOLOGIES

CCT is actively seeking investors who are interested in being part of our dynamic pipeline of products. We invite you to explore investment opportunities with us. If you are interested, please don’t hesitate to contact us at
Investorrelations@cnscurative.com

We’re open to seed stage investment transitioning into feasibility manufacture development of prototypes. After, CCT will phase in immediately into manufacture of pilot scale batch (March to August) 2024) into go to market product launch 3 months and, commercial scale on demand e-commerce sales (after September 2024)